## Table of Contents


1. [Aryl Hydrocarbon](#aryl-hydrocarbon)
2. [Androgen](#androgen)  
3. [Estrogen](#estrogen)
4. [Glucocorticoid](#glucocorticoid)    
5. [Liver X](#liver-x)
6. [Retinoic-Acid](#Retinoic-Acid)
7. [Thyroid](#thyroid)
 

****

## Aryl Hydrocarbon

#### * AGONIST VS. INHIBITOR *  

### 1.1 CTL04  
AHR_AG behaves in the opposite way to RET_AG. AHR_INH is similar to ANDR_INH.  

<details>
<summary>UP 4E</summary>

* **DHPS** (encodes the protein required for hypusine formation on eukaryotic translation initiation factor 5A; associated with neurodevelopmental delay)  
* **CALCA** (calcitonin; regulates calcium and cerebral vasodilation; expressed in the parabrachial nucleus by glutamatergic neurons mediating pain response)  
* **FOXA1** (modulates nuclear hormone receptor transcriptional activity; involved in [ESR1-mediated transcription](https://pubmed.ncbi.nlm.nih.gov/15858227/); required for ESR1 binding to the NKX2-1 promoter in breast cancer; binds the RPRM promoter for estrogen-induced repression; in mouse, important for subthalamic nucleus development)  
* **HSPA1A** (heat shock protein)  
* **NTS** (neurotensin; involved in analgesia, thermoregulation, reward, arousal, blood pressure, feeding; alterations described in obesity and eating disorders)  
* **HSPA1B**, **HSPA5**, **HSPH1** (heat shock proteins)  
* **PPP1R3C** (activates glycogen synthase; limits glycogen breakdown by reducing glycogen phosphorylase activity)  
* **MGAM2** (maltase-glucoamylase 2)  

</details>

<details>
<summary>DOWN 4E</summary>

* **CRH** (corticotropin-releasing hormone; fundamental for HPA axis; limits neuronal maturation)  
* **COL3A1** (type III collagen; regulates cortical development; mutations cause brain structure abnormalities)  
* **SPX** (spinxin neuropeptide; controls food intake and stress response)  
* **CARTPT** (CART neuropeptide; roles in reward, feeding, stress; endogenous psychostimulant)  
* **OTP** (controls neuroendocrine hypothalamus development)  
* **CXCL14** (inhibits glutamatergic transmission in the dentate gyrus in mouse)  
* **ANKRD30B** (downregulated in Williams syndrome)  
* **HHIP** (hedgehog-interacting protein; regulates limb patterning and left-right asymmetry)  
* **FAR2** (fatty acyl reductase; converts fatty acids to fatty alcohols in wax biosynthesis)  
* **PENK** (proenkephalin; binds μ- and δ-opioid receptors to modulate pain perception)  

</details>

### 1.2 CTL08
<details>
<summary>UP 8A</summary>

* **SAPCD1** (associated with developmental epileptic encephalopathy and Alzheimer’s in GWAS; function unknown)  
* **CABCOCO1** (predicted calcium-binding; localized to centrosome, cytoplasm, sperm flagellum)  
* **GLYCTK** (glycerate kinase; may be involved in serine degradation and fructose metabolism)  
* **DERL3** (involved in ER-associated degradation of misfolded glycoproteins)  
* **CAPS** (calcium-binding protein; may regulate ion transport)  
* **EIF4EBP3** (binds eIF4E to regulate assembly of EIF4F initiation complex)  
* **CCT6B** (important for protein folding)  
* **MT-CO1** (mitochondrial cytochrome c oxidase I; involved in proton-coupled electron transport)  
* **CIRBP** (cold-inducible RNA-binding protein; stabilizes transcripts in genotoxic stress; translational activator)  
* **RBM3** (stimulates neuronal differentiation; inhibits hypoxic-ischemic apoptosis; promotes NSPC proliferation)  

</details>

<details>
<summary>DOWN 8A</summary>

* **UTP14C** (involved in meiotic cell cycle, rRNA processing, spermatogenesis)  
* **NPC1L1** (mediates intestinal cholesterol uptake)  
* **HSPA6** (heat shock protein)  
* **PPP1R16B** (regulates PI3K/AKT signaling, angiogenesis, endothelial proliferation)  
* **TNR** (tenascin-R; neurite outgrowth, cell adhesion, sodium channel modulation; component of perineuronal nets; associated with neurodevelopmental disorder with spasticity)  
* **H2BC7** (histone; associated with developmental epileptic encephalopathy)  
* **ABLIM3** (actin-binding protein; neurodevelopmental roles)  
* **GRIN2B** (NMDA receptor subunit)  
* **H4C9** (histone)  
* **KCNJ9** (inward-rectifier potassium channel)  
* **KCNS2** (voltage-gated potassium channel subunit)  

</details>

### 1.3 Line comparisons  
By comparing AHR_AG vs AHR_INH it is strikingly clear that INH is similar to LX_AG, RET_AG, THYR_INH, and GC_INH.

<details>
<summary>UP 4E, DOWN 8A</summary>

* **FLNC** (filamin C; central to sarcomere assembly and organization)  
* **HSPA6** (heat shock protein)  

</details>

<details>
<summary>DOWN BOTH</summary>

* **PPP1R16B** (regulates PI3K/AKT signaling and angiogenesis; [PubMed:25007873](https://pubmed.ncbi.nlm.nih.gov/25007873/))  
* **VGF** (neuropeptide precursor; roles in neurogenesis, plasticity, learning, memory, depression, chronic pain)  
* **SPRY4** (suppresses insulin receptor and EGFR-MAPK signaling)  
* **NKX1-2** (neural crest competence factor; [ResearchGate figure](https://www.researchgate.net/figure/FGF-signaling-and-Nkx12-expression-provides-competence-for-neural-crest-induction-A-G_fig4_263934932))  
* **NEFL** (neurofilament light; maintains neuronal caliber; roles in intracellular transport and migration)  
* **C4orf50** (unknown)  
* **CNTN1** (contactin-1; essential for neuronal migration and process formation via RhoA signaling)  
* **ONECUT2** (chromatin regulator; expression negatively correlates with AR activity in prostate cancer; [PMC8992592](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992592/))  
* **FRRS1L** (AMPA receptor complex component; modulates glutamate signaling; linked to neurodevelopmental deficits)  

</details>

## Androgen

### 2.1 CTL04  
ANDR_AG impacts the female line in a similar way to RET_AG. Genes upregulated by ANDR_AG are also upregulated by GC, LX, and THYR inhibitors. Conversely, genes downregulated in ANDR_AG are also downregulated in GC, LX, and THYR inhibitors.

#### * AGONIST VS. INHIBITOR *  

<details>
<summary>UP 4E</summary>

* **TBC1D3** – With a log₂ fold change of 25, [TBC1D3 promotes neural progenitor proliferation by suppressing the histone methyltransferase G9a](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7810367/) and [induces cortical folding in mice](https://doi.org/10.7554/eLife.18197).  
* **CALCA** – Encodes procalcitonin, which is processed into calcitonin (regulates calcium and phosphate levels) and calcitonin gene-related peptide (CGRP), a neuropeptide involved in pain modulation and vasodilation; procalcitonin has been proposed as a [marker for hypoxic brain damage](https://ccforum.biomedcentral.com/articles/10.1186/cc1760).  
* **HSPE1-MOB4** – Linked with Alzheimer’s disease in [Cell Systems](https://www.cell.com/cell-systems/pdf/S2405-4712(16)30370-2.pdf).  
* **HSPA6** – Stress marker in postmitotic neurons and centriole stabilization; [expressed under genotoxic stress](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3982026/).  
* **HSPA1A** & **HSPA1B** – Members of the HSP70 family; stabilize proteins and assist folding; [potential biomarkers in Alzheimer’s disease](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9553556/).  
* **CRYAB** – Alpha B-crystallin, a small heat shock protein with a [neuroprotective role](https://pubmed.ncbi.nlm.nih.gov/17568699/) in ischemia and oxidative stress.  
* **BAG3** – Binds HSP70 and regulates its GTPase activity; inhibits apoptosis and regulates neuronal development; involved in CNS pathogenesis ([Wiley J Cell Biol](https://onlinelibrary.wiley.com/doi/epdf/10.1002/jcb.29952)).  
* **HSPB8** – Small heat shock protein, upregulated in ASD contexts.  
* **DNAJB1** – HSP family chaperone; critical in brain stress response ([PMC2939168](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2939168/)).  
* **SPR** – Sepiapterin reductase; synthesizes tetrahydrobiopterin, a cofactor for dopamine and serotonin production; [upregulated in Parkinson’s disease brain](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1868471/).  

</details>

<details>
<summary>DOWN 4E</summary>

* **HOXC8** – Homeobox transcription factor; [promotes motor neuron differentiation](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8940177/).  
* **HOXC10** – Homeobox factor; promotes glioma proliferation.  
* **DBX2** – Homeobox factor regulating V0 and V1 interneuron phenotypes; [role in hypothalamic development](https://neuraldevelopment.biomedcentral.com/articles/10.1186/s13064-016-0067-9).  
* **VSX2** – Homeobox factor in retina specification and V2a interneuron development.  
* **TBC1D3H** – GTPase activity; highly upregulated by agonist.  
* **GPR45** – G protein–coupled receptor in cortex; function uncharacterized.  
* **EMILIN3** – Collagen-matrix protein; pro–TGF-β antagonist in mouse brain ([PMC3322879](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3322879/)).  
* **NKX1-2** – Homeobox factor in cell differentiation and transcription; [promotes adipogenesis](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885646/) and developmental patterning.  
* **DRAM1** – p53 pathway–regulated lysosomal protein; required for autophagy and apoptosis regulation.  
* **INHA** – TGF-β superfamily ligand; regulates FSH; implicated in proliferation and infertility.  
* **TP53I3** – p53-induced gene involved in p53-mediated cell death; linked to brain tumors.  
* **BEST4** – Bestrophin-family anion channel, highly expressed in colon.  
* **SLC25A10** – Mitochondrial dicarboxylate transporter.  

</details>

### 2.2 CTL08

<details>
<summary>UP 8A</summary>

* **FOXD4L5** – Forkhead transcription factor; associated with familial adult myoclonic epilepsy.  
* **GPR83** – Neuropeptide receptor; implicated in Alzheimer’s pathways and glucocorticoid signaling.  
* **TTN** – Titin; critical for muscle assembly; SFARI gene.  
* **VGF** – Neuropeptide precursor in learning, memory, depression, and pain.  
* **FOXD4** – Forkhead factor; linked to 9p deletion syndrome and developmental disorders.  
* **DOC3** – Involved in Ras and receptor tyrosine kinase signaling.  
* **GRP** – Gastrin-releasing peptide; regulates GI and CNS functions.  
* **H3C6** – Histone protein.  
* **SHC4** – Adaptor protein in VEGF and prolactin signaling; postsynaptic membrane localization.  
* **CAVIN4** – Caveolae protein; promotes Rho/ROCK signaling in muscle.  

</details>

<details>
<summary>DOWN 8A</summary>

* **LINC02210-CRHR1** – Readthrough transcript of CRHR1; encodes corticotropin-releasing hormone receptor 1.  
* **TRPM4** – Calcium-activated nonselective cation channel.  
* **CDKN1A** – Cyclin-dependent kinase inhibitor p21; regulates G1 cell cycle.  
* **PLCD1** – Phospholipase C δ1; generates DAG and IP₃.  
* **TXNIP** – Thioredoxin-binding protein; regulates redox signaling.  
* **SLC16A3** – Monocarboxylate transporter MCT4.  
* **GDF15** – TGF-β superfamily ligand; activates SMAD transcription factors.  
* **DOCK6** – Atypical GEF for Rho GTPases.  
* **PIK3IP1** – PI3K inhibitory protein; negative regulator of PI3K signaling.  
* **BCKDHA** – BCKD E1 α subunit; branched-chain amino acid catabolism; mutations cause maple syrup urine disease.  

</details>

### 2.3 Line comparisons

<details>
<summary>UP 4E, DOWN 8A, AGONIST VS. DMSO</summary>

* **SNX31** – Sorting nexin involved in trafficking; dysregulated in AD, Down syndrome, schizophrenia, ataxia, and epilepsy ([Springer Mol Neurobiol](https://link.springer.com/article/10.1007/s12035-021-02388-9)).  

</details>

<details>
<summary>UP BOTH</summary>

* **H3C6** – Histone protein  

</details>


## Estrogen

### 3.1 CTL04  
ESTR_AG has little transcriptomic impact on the female line, while ESTR_INH shows low effects but clear overlap with GC, THYR, and LX inhibitors.  
4E: 58 DEGs, 32 UP, 26 DOWN  
8A (vs DMSO): 1702 DEGs, 905 UP, 797 DOWN

#### * AGONIST VS. INHIBITOR *  

<details>
<summary>UP 4E</summary>
  
* **HOXC8**: Upregulated by ESTR_AG (log₂FC 31) and inhibited by ANDR_AG (log₂FC –20).  
* **TBC1D3**: Strongly upregulated, as with ANDR_AG.  
* **AC008770.4**: uncharacterized.  
* **HOXB2**: HOX family transcription factor regulating embryonic patterning.  
* **RPH3A**: Rab effector regulating neurotransmitter release; interacts with GluN2A‐containing NMDARs to promote synaptic retention ([PMID 35467084](https://pubmed.ncbi.nlm.nih.gov/35467084/), [Nat Commun 6, 10181](https://www.nature.com/articles/ncomms10181)).  
* **POU4F3**: POU-domain transcription factor in retinal neurons.  
* **SLC13A4**: Sulfate transporter critical for postnatal brain development; haploinsufficiency impairs social interaction and memory and increases neurogenesis ([Science 361, S2352396419302245](https://www.sciencedirect.com/science/article/pii/S2352396419302245), [PMC7406315](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7406315/)).  
* **FGF1**: Protects cells under stress and regulates metabolism; secreted into CSF after hypercaloric challenge ([NCBI Gene 2246](https://www.ncbi.nlm.nih.gov/gene/2246), [Nat Metab 4, 830](https://www.nature.com/articles/s42255-022-00580-2)).  
* **PPP1R1B**: DARPP-32; modulates dopamine/glutamate signaling; SFARI gene; therapeutic target in psychiatry ([PMC1784004](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1784004/)).  
* **OTOF**: Calcium sensor at ribbon synapses; essential for neurotransmitter release; associated with deafness.  
</details>

<details>
<summary>DOWN 4E</summary>
  
* **HSPA6**: Stress marker in post-mitotic neurons; centriole-localized under stress ([PMC3982026](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3982026/)).  
* **CALCA**: Procalcitonin precursor to calcitonin and CGRP; proposed hypoxic brain damage marker ([Crit Care 9, R107](https://ccforum.biomedcentral.com/articles/10.1186/cc1760)).  
* **CRYAB**: αB-crystallin; neuroprotective small HSP in astrocytes; proposed oligodendrocyte marker ([PubMed 17568699](https://pubmed.ncbi.nlm.nih.gov/17568699/), [Nature 613, MOESM2](https://www.nature.com/articles/s41587-023-01937-y#MOESM2)).  
* **NPAS4**: Activity-dependent transcription factor for synaptic plasticity; implicated in schizophrenia and ASD ([TINS 39, 127](https://doi.org/10.1016/j.tins.2016.02.003), [Stem Cell Res 6, 453](https://stemcellres.biomedcentral.com/articles/10.1186/scrt453)).  
* **PITX2**: RIEG/PITX homeobox factor; required for subthalamic nucleus and midbrain neuron development ([PubMed 14975719](https://pubmed.ncbi.nlm.nih.gov/14975719/)).  
* **FOXA1**: Regulates estrogen signaling and dopaminergic neuron development ([PNAS 112, E1235](https://www.pnas.org/doi/10.1073/pnas.1503911112), [Sci Rep 6, 38611](https://www.nature.com/articles/srep38611)).  
* **GADD45B**: Activity-induced DNA demethylation for adult neurogenesis; regulates BDNF and FGF expression ([PMC2726986](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2726986/)).  
* **SHOX2**: Homeobox factor; shapes thalamocortical neuron firing; seizure suppression ([Cereb Cortex 31, 3194](https://academic.oup.com/cercor/article/31/7/3194/6155833)).  
* **H2BC8**: Histone protein.  
* **GPNMB**: Microglial glycoprotein; neuroinflammation regulator; expressed in astrocytes ([PMC6557242](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6557242/)).  
</details>

### 3.2 CTL08

#### * AGONIST VS. DMSO *  
<details>
<summary>UP 8A</summary>
  
* **SCGN**: Secreted calcium-binding protein in forebrain; altered in AD; linked to neurodevelopmental disorders ([Front Mol Neurosci 12, 29](https://www.frontiersin.org/articles/10.3389/fnmol.2019.00029/full), [PMC6591208](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6591208/), [PNAS 117, 281](https://www.pnas.org/doi/10.1073/pnas.1919698117)).  
* **PCDHA13**: Cadherin-like adhesion protein; critical for neuronal connections; linked to autism spectrum disorder ([PMC3633712](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3633712/)).  
* **ETV4**: ETS transcription factor; required for hippocampal dendrite development ([Cereb Cortex 28, 236](https://academic.oup.com/cercor/article/28/1/236/2623041)).  
* **ST8SIA6**: Sialyltransferase; synthesizes sialylglycoconjugates.  
* **MARCO**: Macrophage scavenger receptor in innate immunity.  
* **RPH3A**: Rab3A effector; upregulated in AD ([BMC Neurol 21, 407](https://bmcneurol.biomedcentral.com/articles/10.1186/s12883-021-02407-1)).  
* **LMO2**: LIM-domain protein essential for hematopoiesis.  
* **VGF**: Neuropeptide precursor; roles in plasticity, memory, depression, pain ([PubMed 10882540](https://pubmed.ncbi.nlm.nih.gov/10882540/), [Sci Direct 75, 333](https://www.sciencedirect.com/science/article/pii/S0753332222004887)).  
* **TPBGL**: Wnt signaling regulator; candidate PD gene ([PMC8651753](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8651753/)).  
* **GPR83**: Neuropeptide receptor; involved in glucocorticoid response; regulates feeding and anxiety ([PubMed 27117253](https://pubmed.ncbi.nlm.nih.gov/27117253/)).  
</details>

<details>
<summary>DOWN 8A</summary>
  
* **LBX1**: Homeobox factor for GABAergic interneuron development ([J Neurosci 27, 4902](https://www.jneurosci.org/content/27/18/4902)).  
* **PDCD6-AHRR**: AHR repressor; likely calcium-binding.  
* **AL035461.3**: uncharacterized.  
* **SLC6A5**: Glycine transporter; mutations cause hyperekplexia.  
* **AC010422.6**: uncharacterized.  
* **TAC3**: Neurokinin B precursor; functions in CNS and placenta; mutations cause hypogonadotropic hypogonadism.  
* **PRDM13**: Regulates Kiss1 neuron differentiation and cerebellar GABAergic fate.  
* **SOX21**: Represses neuronal differentiation; regulates progenitor expansion ([PMC4325979](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4325979/)).  
* **LHX1**: LIM homeobox factor for interneuron migration ([PubMed 29912395](https://pubmed.ncbi.nlm.nih.gov/29912395/)).  
* **OLIG3**: Oligodendrocyte factor; regulates cerebellar development ([eLife 9, 64684](https://elifesciences.org/articles/64684)).  
* **FGFR3**, **NDNF**, **THRB**, **FOXB1**: unmodified.  
</details>

### 3.3 Line comparisons  
No shared DEGs across the two datasets.

## Glucocorticoid

#### * AGONIST VS. INHIBITOR *

### 4.1 CTL04  
GC_AG shows minimal effects, while GC_INH has a substantial impact, overlapping extensively with THYR, ESTR, and LX inhibitors ([PMID 22457708](https://pubmed.ncbi.nlm.nih.gov/22457708/)).  
Applying thresholds of |Log₂FC| ≥ 1 and FDR ≤ 0.01 yields 544 genes: 373 up-regulated and 171 down-regulated.

<details>
<summary>UP 4E</summary>

* **HOXC8** and **HOXC6** – Homeobox transcription factors specifying rostrocaudal neuronal identity ([Sci Signal 6, ra44](https://www.sciencedirect.com/science/article/pii/S0896627313008519)).  
* **SFRP4** – WNT pathway antagonist; WNT signaling regulates neural plate specification, tube formation, precursor migration, dendritogenesis, and synaptic plasticity; implicated in PCB-95 neurotoxicity and ASD/schizophrenia risk ([PMC5318929](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5318929/)).  
* **ACTG2** – Gamma-actin isoform.  
* **AZGP1** – Zinc-α2-glycoprotein; SFARI gene; reduced in epilepsy; promotes lipid metabolism and brain insulin sensitivity.  
* **ENG** – Endoglin; endothelial homeostasis in cerebral ischemia–reperfusion injury ([PMID 35806090](https://pubmed.ncbi.nlm.nih.gov/35806090/)).  
* **TNMD** – Tenomodulin; chondromodulin-family glycoprotein stimulating chondrocyte growth and inhibiting endothelial tube formation.  
* **NPY** – Neuropeptide Y; regulates cortical excitability, stress, feeding, circadian rhythms, cardiovascular function; altered distribution in schizophrenia ([PMID 14751436](https://pubmed.ncbi.nlm.nih.gov/14751436/)).  
* **APOL4** – Apolipoprotein L4; cholesterol transport; associated with schizophrenia.  
* **FZD6** – Frizzled-6; negative regulator of WNT signaling.  

</details>

<details>
<summary>DOWN 4E</summary>

* **OTX2** – Transcription factor for dopaminergic progenitor proliferation and differentiation ([PMC6724764](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6724764/)).  
* **HSPA1A**, **HSPA1B**, **HSPA6**, **HSPA8**, **HSPH1**, **DNAJB1** – Heat shock proteins.  
* **CHORDC1** – HSP90 co-chaperone; involved in centrosome duplication and heat response.  
* **CPT1A** – Carnitine palmitoyltransferase 1A; essential for mitochondrial β-oxidation of long-chain fatty acids.  
* **FOXA1** – Modulates steroid hormone receptor activity; upregulated by AHR in CTL04E ([PMC8533709](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533709/)).  
* **LIN28A** – RNA-binding protein for developmental timing and stem cell self-renewal; enriched in proliferating NPCs ([PMC4419280](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4419280/)).  

</details>

### 4.2 CTL08  
GC_AG modulates very few genes but strongly downregulates **NDNF**, which guides GnRH neuron migration ([PMID 31883645](https://pubmed.ncbi.nlm.nih.gov/31883645/)) and promotes neurite outgrowth.  
GC_INH regulates 350 genes (244 up-, 56 down-regulated), including sleep-related and stem cell proliferation genes.

<details>
<summary>UP 8A</summary>

* **HOXB3** – Homeobox factor regulating rostral brain and motor/sensory neuron identity ([Dev 131, 1259](https://journals.biologists.com/dev/article/131/6/1259/64441/Contribution-of-Hox-genes-to-the-diversity-of-the)).  
* **HAPLN4** – Perineuronal net component; organizes GABAergic synapses between Purkinje and cerebellar nuclei neurons ([PMID 30125937](https://pubmed.ncbi.nlm.nih.gov/30125937/)).  
* **PDCD6-AHRR** – AHR repressor; competes for ARNT binding to XRE elements.  
* **NPY** – See above; upregulated in CTL04E.  
* **PROKR1** – Prokineticin receptor in angiogenesis and inflammation.  
* **GDF10** – TGF-β superfamily ligand.  
* **RHOJ** – Rho GTPase in focal adhesions; regulates spine morphology and plasticity ([Front Cell Dev Biol 9, 729076](https://www.frontiersin.org/articles/10.3389/fcell.2021.729076/full)).  
* **SPACD1** – Linked to CNS sarcoma and developmental epileptic encephalopathy.  
* **ATP1A2** – Na⁺/K⁺-ATPase α2; maintains electrochemical gradients.  
* **SFRP5** – WNT antagonist related to SFRP4.  

</details>

<details>
<summary>DOWN 8A</summary>

* **HSPB6-MOB4** – Heat shock protein.  
* **H2BC5**, **H2BC7**, **H2BC8**, **H4C5**, **H4C9**, **H2BC11**, **H2AC11** – Histones (H4C5 and H2BC11 are SFARI genes).  
* **SAGSIN1** – Salivary gland–specific protein, uncharacterized.  
* **SP8** – Transcription factor for olfactory interneuron development ([PMID 28981617](https://pubmed.ncbi.nlm.nih.gov/28981617/)).  

</details>

### 4.3 Line comparisons  
<details>
<summary>UP BOTH</summary>

* **PROKR1** – See above; [Circulating PROK1 levels are elevated in first-trimester pregnancy](https://pubmed.ncbi.nlm.nih.gov/27172869/).  
* **NPY** – See above.  
* **ATP1A2** – See above; mutations cause epilepsy and hemiplegia ([PMID 33578253](https://pubmed.ncbi.nlm.nih.gov/33578253/)).  
* **FGF1** – Maintains NSPC proliferation and self-renewal ([PMID 19409495](https://pubmed.ncbi.nlm.nih.gov/19409495/)).  
* **RHOJ** – See above.  
* **ALDH1L1** – Astrocyte marker; catalyzes 10-formyltetrahydrofolate to THF and NADPH ([PMC3777382](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3777382/)).  
* **IFI44** – Predicted immune response regulator.  
* **HSD17B8** – 17β-HSD enzyme in steroid metabolism.  
* **FBLN5** – Elastogenesis and endothelial adhesion ([PMID 18185537](https://pubmed.ncbi.nlm.nih.gov/18185537/)).  
* **CD9** – Tetraspanin in adhesion and metastasis suppression.  

</details>

<details>
<summary>DOWN BOTH</summary>

* **CPT1A** – See above.  
* **HSPE1-MOB4**, **DNAJB1**, **HSPA1B**, **HSPH1**, **HSPA6** – Heat shock proteins.  
* **H2BC5**, **H4C9** – Histones.  
* **CHORDC1** – See above.  
* **AL031777.2** – Histone.  

</details>

## Liver X

##### * AGONIST VS. INHIBITOR *

### 5.1 CTL04  
Applying thresholds of |Log₂FC| ≥ 1 and FDR ≤ 0.01 yields 483 genes: 291 up-regulated and 192 down-regulated.

<details>
<summary>UP 4E</summary>

* **TBC1D3**: promotes basal neural progenitor proliferation by suppressing histone methyltransferase G9a in human cerebral organoids ([PMID 33523893](https://pubmed.ncbi.nlm.nih.gov/33523893/)).  
* **SREBF1** (ND gene): transcription factor that binds sterol regulatory elements in promoters of cholesterol biosynthesis genes (e.g., HMGCR, LDLR), promoting fatty acid and cholesterol synthesis and uptake.  
* **ABCA1** (conc ASD up) and **ABCG1**: astrocytic transporters that export cholesterol to ApoE lipoproteins, supporting neuronal cholesterol supply.  
* **LPCAT3**: part of the LXR/NR1H3–NR1H2 pathway; catalyzes triacylglycerol transfer to nascent VLDL; counteracts lipid-induced ER stress and inflammation; participates in PUFA synthesis and phospholipid remodeling ([PMC4436788](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4436788/)).  
* **MYLIP**: LXR induces MYLIP, an E3 ligase that ubiquitinates and degrades LDLR, VLDLR, and APOE receptor as a counter-regulatory mechanism ([PMC6433546](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6433546/)).  
* **C1R** (conc ASD up) and **C1RL**: proteolytic subunits of complement C1; mediate innate immunity but no known brain role.  
* **MLIP**: associated with cardiomyopathy.  
* **ZSCAN1**: zinc-finger transcription factor; binds double-stranded DNA; regulates RNA polymerase II transcription.

</details>

<details>
<summary>DOWN 4E</summary>

* **DBX1** and **DBX2**: homeobox factors specifying V0 and V1 interneurons; DBX1 also controls spinal astrocyte development via Notch signaling ([Neural Dev 7, 28](https://neuraldevelopment.biomedcentral.com/articles/10.1186/1749-8104-7-28), [Dev 149, dev200750](https://journals.biologists.com/dev/article/149/15/dev200750/276178/Dbx1-controls-the-development-of-astrocytes-of-the)).  
* **VSX2**: homeobox factor in sensory retina specification; may specify V2a spinal interneurons by similarity.  
* **HSPA6**, **HSPA1A**, **HSPA1B**: heat shock proteins.  
* **SHOX2**: homeobox factor shaping thalamocortical neuron firing and suppressing seizures ([PMC8196244](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8196244/)).  
* **NEUROG1**: proneural factor for cranial nerve development and neural crest differentiation; mutations linked to autism spectrum disorder; specifies cortical glutamatergic neurons ([Neural Dev 7, 28](https://neuraldevelopment.biomedcentral.com/articles/10.1186/1749-8104-7-28)).  
* **PRDM12**: regulator of sensory neuron specification and pain perception; required for V1 interneuron generation ([Neural Dev 14, 29](https://neuraldevelopment.biomedcentral.com/articles/10.1186/s13064-019-0129-x)).  
* **CRH** (conc ASD down): corticotropin-releasing hormone.  
* **TRIM48**: predicted ubiquitin ligase; involved in innate immunity.

</details>

### 5.2 CTL08  
Applying thresholds of |Log₂FC| ≥ 1 and FDR ≤ 0.01 yields 614 genes: 440 up-regulated and 174 down-regulated.

<details>
<summary>UP 8A</summary>

* **HOXA3**: homeobox factor specifying visceral sensory neurons and formation of thymus, thyroid, and parathyroid ([PMC3835187](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3835187/)).  
* **KCNK12**: potassium channel linked to developmental and epileptic encephalopathy.  
* **SREBF1** (ND gene): see above.  
* **APOE** (ND gene; conc ASD up): astrocyte-to-neuron cholesterol shuttle.  
* **ABCA1**/**ABCG1** (conc ASD up): see above.  
* **H4C8**, **H3C6**: histone proteins.  
* **MYLIP**: inhibits neurite outgrowth via LDLR degradation; sterol-dependent regulator of cholesterol uptake.  
* **PCDH11Y**: protocadherin in CNS cell–cell recognition during development.  
* **UPP2**: uridine phosphorylase; upregulated by LXR agonist; involved in dCMP and uridine catabolism; in intermediate filaments.

</details>

<details>
<summary>DOWN 8A</summary>

* **AMIGO3**: predicted synapse assembly regulator and adhesion molecule.  
* **SAPCD1**: CNS sarcoma and epileptic encephalopathy gene.  
* **LBX1**: development of spinal GABAergic interneurons.  
* **SCARA3** (ND gene): oxidative stress protection.  
* **PDCD6-AHRR**: AHR repressor.  
* **S100A16**: calcium-binding; mediates lipogenesis.  
* **GSTZ1**: glutathione-dependent detoxification.  
* **TRAPPC6A** (ND gene): vesicle tethering to cis-Golgi.  
* **GLYCTK**: glycerate kinase in serine degradation and fructose metabolism.  
* **HSD17B8**: estradiol and androgen inactivation.

</details>

### 5.3 Line comparisons

<details>
<summary>UP BOTH</summary>

* **MYLIP**: see above; NGF downregulates MYLIP to promote LDLR-mediated neurite outgrowth ([J Neurochem 142, 805](https://onlinelibrary.wiley.com/doi/10.1111/jnc.13397)).  
* **LPCAT3**: phospholipid remodeling (Lands cycle).  
* **PROKR1**: prokineticin receptor; angiogenesis/inflammation; [PMID 27172869](https://pubmed.ncbi.nlm.nih.gov/27172869/).  
* **ADAMTS3**: cleaves reelin for cortical lamination; type II collagen propeptide processing ([PMC6596773](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6596773/)).  
* **ACSL3**: acyl-CoA synthetase for lipid synthesis and β-oxidation; required for VLDL lipidation ([PMID 22633490](https://pubmed.ncbi.nlm.nih.gov/22633490/), [PMID 18003621](https://pubmed.ncbi.nlm.nih.gov/18003621/)).  
* **CASQ1**: calsequestrin, muscle Ca²⁺ store.  
* **SHFL**: interferon-stimulated viral inhibitor.

</details>

<details>
<summary>DOWN BOTH</summary>

* **DERL3**: ER-associated degradation of misfolded proteins.  
* **ARHGAP45**: Rho GAP linked to bipolar disorder and axon guidance ([PMC6471118](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6471118/)).  
* **AC099489.1**: uncharacterized.

</details>

<details>
<summary>UP 8A, DOWN 4E</summary>

* **SNX31**: sorting nexin in protein trafficking.  
* **H4C8**, **H2BC5**, **H2BC6**, **H2BC8**, **H2AC6**, **H2BC7**: histones.  
* **HSPH1**: heat shock protein.  
* **FOS**: immediate-early gene in neuronal activation ([Science 240, 313](https://www.science.org/doi/10.1126/science.3131879)).  
* **AL031777**: uncharacterized.

</details>

<details>
<summary>DOWN 8A, UP 4E</summary>

* **HSD17B8**: see above.  
* **PYCR3**: proline synthesis.  
* **PRODH** (SFARI): proline degradation.  
* **GGACT**: degrades transglutaminase-crosslinked proteins.  
* **PCK2**: mitochondrial PEP carboxykinase in gluconeogenesis.  
* **DNPH1**: deoxyribonucleotide hydrolase.  
* **GDF15**: stress-response TGF-β ligand linked to brain disorders ([PMC8456456](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8456456/)).  
* **ART5**: arginine-specific ADP-ribosyltransferase.  
* **TMEM129**: ER ubiquitin ligase in ERAD.  
* **HINT2**: mitochondrial AMP-NH₂ hydrolase.

</details>

## Retinoic Acid

### 6.1 CTL04  
RA_AG has the most pronounced effect, clustering separately from other treatments with minimal overlap. Many genes downregulated by RA_AG are also downregulated by RET_INH, suggesting a shared biological response rather than a general chemical stress. These overlapping genes warrant GO/KEGG analysis.  

Nice [review on HOX family genes during neurodevelopment](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3835187/).

<details>
<summary>UP 4E</summary>
  
* **HOXC8**: Homeobox transcription factor in A–P patterning and early nervous system development; promotes terminal motor neuron differentiation ([PMC8940177](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8940177/)).  
* **HOXB8**, **HOXA5**, **HOXB3**, **HOXB7**: See review above.  
* **DBX2**: Developing brain homeobox 2; regulates neural patterning in brain and spinal cord.  
* **HOXA1**: Master ATRA target; positions hindbrain segments; linked to ASD (SFARI gene).  
* **HOPX**: Marker of neurogenic sites; regulates stem cell proliferation/differentiation in dentate gyrus.  
* **NXPH2** + **NXPH1**: Neurexophilins modulate synaptic plasticity; alpha-neurexin binding in [synapse formation](https://academic.oup.com/hmg/article/23/18/4846/2900758) and linked to epilepsy ([PMC3977266](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3977266/)).  
* **NECAB1**: Neuronal calcium-binding; interneuron marker ([DOI 10.1093/cercor/bhaa326](https://doi.org/10.1093/cercor/bhaa326)).  
* **VSNL1**: Neuronal calcium sensor; altered in schizophrenia ([NeuroReport 13, 575](https://journals.lww.com/neuroreport/Abstract/2002/03250/Hippocampal_expression_of_the_calcium_sensor.6.aspx)).  
* **RASGRP3**: Calcium-binding GEF for HRAS/RAP1A; linked to lupus and cancer.  
* **NWD2**: Involved in synaptic neurotransmitter release signaling ([DOI 10.1016/j.gep.2022.119284](https://doi.org/10.1016/j.gep.2022.119284)).  
* **SKAP2**: Src-kinase adaptor; regulates inflammation and OPC migration/myelination ([PMC34324225](https://pubmed.ncbi.nlm.nih.gov/34324225/), [Nat Commun 12, 2153](https://www.nature.com/articles/s41388-021-02153-1)).  
* **PTPRT**: Receptor tyrosine phosphatase; synapse formation regulator ([DOI 10.1038/emboj.2009.289](https://doi.org/10.1038/emboj.2009.289)).  
* **SPARCL1**: ECM protein promoting excitatory synapse formation ([J Neurosci 40, 8088](https://www.jneurosci.org/content/40/42/8088)).  
* **TFPI**: Tissue factor pathway inhibitor; anticoagulant modulated by hormones in plasma.  

</details>

<details>
<summary>DOWN 4E</summary>
  
* **TFAP2B**: AP-2β transcription factor; controls facial/limb development; regulates sleep via GABAergic neurons ([Sci Rep 13, 34772](https://www.nature.com/articles/s41598-023-34772-x), [DOI 10.3389/fnmol.2017.00281](https://doi.org/10.3389/fnmol.2017.00281)).  
* **GSX1**: Homeobox factor in telencephalic progenitor maturation.  
* **ZIC1**, **ZIC2**, **ZIC3**, **ZIC4** (conc ASD down): Zinc-finger factors in neural tube, neurogenesis, and left–right patterning ([PMC15733262](https://pubmed.ncbi.nlm.nih.gov/15733262/), [DOI 10.1016/j.mcn.2004.01.004](https://doi.org/10.1016/j.mcn.2004.01.004)).  
* **CCR7**: Chemokine receptor induced by EBV; mediates inflammation.  
* **CNPY1**: FGF cofactor in midbrain–hindbrain boundary patterning.  
* **TRIM48**: Predicted E3 ligase in innate immunity.  
* **RSPO1**: WNT agonist; regulates astroglial proliferation ([PMC6551209](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6551209/)).  
* **EFCC1**: Coiled-coil, calcium-binding.  
* **PRODH** (SFARI): Mitochondrial proline dehydrogenase; hyperprolinemia and schizophrenia risk ([ORPHA15144](https://www.orpha.net/consor/www/cgi-bin/Disease_Genes.php?lng=EN&data_id=15144)).  
* **EN2** (SFARI): Engrailed-2 homeobox; regulates hippocampal neurogenesis and linked to ASD ([DOI 10.3389/fnana.2018.00061](https://doi.org/10.3389/fnana.2018.00061)).  
* **PI15**: Trypsin inhibitor; overexpressed in neuroblastoma/glioblastoma.  
* **VGLL3**: Transcriptional cofactor; regulates cranial neural crest migration ([DOI 10.1242/bio.026153](https://doi.org/10.1242/bio.026153)).  
* **LEF1**: WNT transcription factor in hippocampal neurogenesis and cancer ([DOI 10.1002/ijc.32742](https://doi.org/10.1002/ijc.32742), [DOI 10.1523/JNEUROSCI.1425-09.2010](https://doi.org/10.1523/JNEUROSCI.1425-09.2010)).  

</details>

### 6.2 CTL08  
RA_AG shares a good amount of upregulated genes with LX_AG and ESTR_AG; many RA_AG–modulated genes show opposite patterns in ANDR_INH.

<details>
<summary>UP 8A</summary>
  
* **HOPX**: See above.  
* **SPHKAP**: AKAP family; region-specific brain expression; linked to childhood schizophrenia ([Cereb Cortex 33, 5774](https://academic.oup.com/cercor/article/33/10/5774/6850566)).  
* **SYNDIG1L**: Synapse differentiation regulator ([PMC20152115](https://pubmed.ncbi.nlm.nih.gov/20152115/)).  
* **AGT**: Angiotensinogen in astrocytes regulating blood pressure ([PMID 12006677](https://pubmed.ncbi.nlm.nih.gov/12006677/)).  
* **VSNL1**: See above.  
* **SYTL5**: Synaptotagmin-like; ASD biomarker in WGS ([QFARC 2016](https://www.qscience.com/content/papers/10.5339/qfarc.2016.HBPP1350)).  
* **CDH1**: E-cadherin in cortical progenitor regulation; linked to microcephaly ([Nat Commun 4, 2879](https://www.nature.com/articles/ncomms3879)).  
* **HRH1**: Histamine receptor; altered in schizophrenia, depression, ASD ([PMC37474883](https://pubmed.ncbi.nlm.nih.gov/37474883/)).  
* **ARX** (SFARI): Homeobox in interneuron migration; X-linked intellectual disability and epilepsy ([PMC2982026](https://www.frontiersin.org/articles/10.3389/fncel.2010.00004/full)).  
* **SPP1**: Osteopontin; injury/inflammation sensor in CNS ([PMC9790650](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9790650/)).  
* **ESRRG**: Estrogen-related receptor gamma.  

</details>

<details>
<summary>DOWN 8A</summary>
  
* **AC010422.6**, **AC008758.1**: uncharacterized.  
* **RSPO1**: See above.  
* **ZIC2**, **ZIC5**: See CTL04E.  
* **EN2**: See CTL04E.  
* **BMP5**: TGF-β ligand with neuroprotective roles.  
* **LMX1A**: LIM homeobox in dopaminergic neuron development.  
* **PRODH**: See CTL04E.  
* **CNPY1**: See CTL04E.  
* **LHX9**: LIM homeobox in cortical pioneer neurons; FGF-regulated.  

</details>

### 6.3 Line comparisons  

<details>
<summary>DOWN 8A / UP 4E</summary>
  
* **C1QL3**: Regulates synapse organization ([PMC5017910](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5017910/)).  

</details>

<details>
<summary>UP BOTH</summary>
  
* **HOPX**, **HTR2C**, **VSNL1**, **NXPH2**, **SPHKAP**, **NOS1**, **CSMD1**, **SYTL5**, **PLPP4**, **SYNDIG1L**: see above descriptions.  

</details>

<details>
<summary>DOWN BOTH</summary>
  
* **RSPO1**, **BMP5**, **EN2**, **CNPY1**, **LHX9**, **ZIC4**, **GSX1**, **TFAP2B**, **DMBX1**, **SIX2**: see above descriptions.  

</details>

## Thyroid

### 7.1 CTL04  
THYR_AG shares some gene signatures with RA_AG, but also overlaps with RA_INH as expected ([MDPI 2022](https://www.mdpi.com/1422-0067/23/5/2708)), while some genes are regulated in opposite directions. Genes modulated by THYR_INH show extensive overlap with LXR, GC, and ESTR inhibitors, consistent with known thyroid crosstalk with steroid hormones, retinoids, glucocorticoids, and estrogens ([MDPI 2022](https://www.mdpi.com/1422-0067/23/5/2708), [PMC8911152](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8911152/)). Interestingly, RA and ANDR inhibitors behave oppositely to THYR_INH.

<details>
<summary>UP 4E</summary>
  
* **HOXC8** and **HOXA5**: Also upregulated in GC_AG; transcription factors for rostrocaudal identity ([Cell Syst. 2016](https://www.sciencedirect.com/science/article/pii/S0896627313008519)).  
* **TBC1D3H**: Also up in LX_AG; GTPase activator that promotes neural progenitor proliferation by suppressing G9a ([PubMed 33523893](https://pubmed.ncbi.nlm.nih.gov/33523893/)).  
* **DIO3**: Inactivates T4 and T3 to reverse T3 and T2, respectively.  
* **CPLX4**: Regulates SNARE-mediated synaptic vesicle fusion.  
* **CD9**: Tetraspanin involved in differentiation, adhesion, and signal transduction; suppresses cancer cell motility.  
* **BDKRB2**: Bradykinin receptor involved in pain, inflammation, and linked to neurodevelopmental disorders.  
* **RPH3A**: RAB3A effector in neurotransmitter exocytosis and NMDA receptor retention.  
* **ETNPPL**: Pyridoxal-phosphate–dependent breakdown of phosphoethanolamine.  
* **TMOD1**: Caps actin filaments, organizing membrane skeleton.  
* **ESRRB**: Estrogen receptor beta; top 15 gene of interest.  

</details>

<details>
<summary>DOWN 4E</summary>
  
* **AC008770.4**: Uncharacterized, metal-ion binding.  
* **HSPA6**, **HSPA1A**, **HSPA1B**, **DNAJB1**: Heat shock proteins.  
* **CALCA**: Encodes calcitonin and CGRP; regulates calcium/phosphorus metabolism.  
* **CPT1A**: Carnitine palmitoyltransferase; imports long-chain fatty acids into mitochondria.  
* **CRYAB**: Small heat shock protein; chaperone activity in lens and neurons.  
* **BAG3**: HSP70 co-chaperone; required for neuronal differentiation and migration ([PMC5397659](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5397659/)).  
* **TNFRSF14**: Member of the TNF receptor superfamily.  

</details>

### 7.2 CTL08  
In CTL08A, GC_INH and THYR_INH have strongly similar impacts, while LX_INH has little effect, and LX_AG modulates many genes. Surprisingly, genes commonly modulated by GC_INH and THYR_INH in CTL08A are also regulated by LX_AG (whereas in CTL04E, they were modulated by LX_INH).

<details>
<summary>UP 8A</summary>
  
* **PDCD6-AHRR**: AHR repressor competing with AHR for ARNT binding ([UCSC hgGene](http://genome.ucsc.edu/cgi-bin/hgGene?db=hg19&hgg_gene=AHRR)).  
* **GDF1**: TGF-β superfamily ligand; establishes left–right asymmetry and neural development.  
* **FAM187A**: Predicted membrane protein.  
* **GLYCTK**: Glycerate kinase; up in AHR_AG, down in LX_AG.  
* **FOXA1**: Hormone receptor cofactor; down in GC_AG, up in AHR_AG ([PMC8533709](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533709/)).  
* **CABCOCO1**: Calcium-binding protein; up in AHR_AG.  
* **SAPCD1**: Associated with CNS sarcoma and epileptic encephalopathy.  
* **CLEC2L**: Carbohydrate-binding receptor.  
* **FBXL9B**: E3 ubiquitin ligase component.  
* **SCARA3**: Antioxidant receptor down in LX_AG.  

</details>

<details>
<summary>DOWN 8A</summary>
  
* **JUNB**: AP-1 transcription factor.  
* **HSPA6**: Heat shock protein.  
* **H2BC7**, **H2BC8**, **H1-2**: Histones.  
* **AL691442**: Uncharacterized.  
* **NPAS4**: Neuronal transcription factor for excitatory–inhibitory balance.  
* **ARC**: Synaptic plasticity regulator forming capsids for mRNA transfer.  
* **GADD45B**: Stress-induced DNA demethylation and adult neurogenesis.  
* **NPC1L1**: Cholesterol transporter; also transports α-tocopherol.  

</details>

### 7.3 Line comparisons

<details>
<summary>UP BOTH</summary>
  
* **TREX1**: 3′–5′ exonuclease in DNA repair.  
* **CABCOCO1**: See above.  
* **APLN**: Apelin ligand for GPCR regulating cardiovascular function.  
* **TNC**: ECM glycoprotein guiding neuronal migration and regeneration.  
* **SLA**: SH2-domain adaptor in immune signaling.  
* **PBLD**: Negative regulator of TGF-β/SMAD signaling.  
* **MATN2**: ECM protein in filamentous networks.  
* **RGS6**: Regulator of G-protein signaling.  
* **CSGALNACT1**: Chondroitin sulfotransferase in perineuronal nets.  
* **ZSCAN1**: Zinc-finger transcription factor.  

</details>

<details>
<summary>DOWN BOTH</summary>
  
* **HSPA6**, **HSPA1B**: Heat shock proteins.  
* **H2BC8**, **H4C8**, **H1-2**: Histones.  
* **NPC1L1**: See above.  
* **CPT1A**: See above.  
* **SNX31**: Phosphatidylinositol-binding sorting nexin.  
* **AL031777.2**: Histone.  
* **TNFRSF14**: See above.  

</details>

